Application of a Bayesian strategy to ABCD: Identification of substance use risk and COVID-19 effects on neurodevelopment
贝叶斯策略在 ABCD 中的应用:识别物质使用风险和 COVID-19 对神经发育的影响
基本信息
- 批准号:10599090
- 负责人:
- 金额:$ 31.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdolescenceAdolescentAdoptionAgeBayesian ModelingBayesian PredictionBayesian learningBehavioralBrainCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 pandemic effectsCessation of lifeChildChild DevelopmentChild HealthCitiesCollaborationsCommunitiesComplexCorpus striatum structureDataData AggregationData CollectionData SetDevelopmentDietary FiberEconomicsEventExhibitsFaceFamily history ofFingerprintFunctional Magnetic Resonance ImagingFutureGenerationsGeographic LocationsGrowthHealthcare SystemsHeightHome environmentHospitalizationIndividualIndividual DifferencesInfectionJointsLaboratoriesLifeLife StyleLinear RegressionsLogisticsLongitudinal StudiesMeasurableMeasuresModelingNeurobiologyNeurosciencesOutcomeParticipantPatientsPhenotypePopulationProbabilityProcessPsychiatryPsychosocial StressPublic HealthRecording of previous eventsRecreationReproducibilityResearchRewardsRiskRoleSeriesSiteSocial DistanceSourceStatistical ModelsStructureSubstance Use DisorderSystemThalamic structureTimeUncertaintyUnemploymentUnited StatesVariantYouthclinical practicecognitive developmentcohortcomplex datacourse developmentearly onset substance useexperienceflexibilityinsightinterestneuralneurodevelopmentnovelpandemic diseasepandemic impactperceived stresspredictive modelingpreventive interventionpsychosocialrepositoryresponseschool closuresocialsocial mediasubstance usetheoriestool
项目摘要
Abstract
Substance use initiation at an early age is associated with numerous negative outcomes, including increased
likelihood of substance use disorders later in life. Multiple lines of evidence indicate that the risk for early
substance use initiation is influenced by individual differences in neural development. The precise neural
developmental mechanisms that give rise to heighted substance-use vulnerability remain poorly understood and
The Adolescent Brain and Cognitive Development (ABCD) study provides an unprecedented opportunity to
elucidate these mechanisms. However, children in this cohort now face a unique developmental challenge:
entering adolescence during the COVID-19 pandemic. In direct response to PAR-19-162 (‘Accelerating the Pace
of Child Health Research Using Existing Data from the ABCD Study’), this application aims to characterize
neurodevelopmental trajectories of substance use risk with specific consideration of the societal and individual
effects of COVID-19. Specifically, using Bayesian machine learning and hierarchical time-series modeling of
longitudinal ABCD data, this proposal will establish, refine, and deploy models of normative trajectories in brain
development and quantify deviations related to substance-use risk (AIM 1). Further, this effort will carefully
contextualize the effects of the COVID-19 crisis as a US-wide event with deep consequences for child
development (AIM 2). As a primary research product of this proposal, all derived models and functional
connectivity metrics will be shared via ABCD’s central repository (AIM 3). This will include (i) complete neural
‘fingerprints’ or functional connectivity matrices for all task-based data from ages 10-14; (ii) derived normative
‘growth curves’, and (iii) the full generative probabilistic models for reuse by other laboratories. This key data
contribution will relieve logistic burdens for a large number of research labs and further promote widespread use
of ABCD data, propelling comparability and reproducibility of single-subject prediction studies towards identifying
a reliable predictor of substance-use initiation in youth. This is a critical step toward precision psychiatry and will
shed light on individual difference factors that contribute to vulnerability in the exigent context of the evolving
COVID-19 pandemic. Such predictors are needed to understand the developmental trajectories of substance-
use phenotypes and to inform early risk models and preventative intervention efforts.
摘要
早期开始使用药物与许多负面结果有关,包括增加
物质使用障碍的可能性以后的生活。多项证据表明,
物质使用起始受神经发育的个体差异的影响。精确的神经
对导致吸毒脆弱性加剧的发展机制仍然知之甚少,
青少年大脑和认知发展(ABCD)研究提供了前所未有的机会,
阐明这些机制。然而,这一群体的儿童现在面临着一个独特的发展挑战:
在新冠肺炎大流行期间进入青春期。直接响应PAR-19-162(“加快步伐
使用ABCD研究的现有数据进行儿童健康研究”),该应用程序旨在表征
物质使用风险的神经发育轨迹,特别考虑社会和个人
COVID-19的影响。具体而言,使用贝叶斯机器学习和分层时间序列建模,
纵向ABCD数据,该提案将建立,完善和部署大脑中的规范轨迹模型
开发和量化与物质使用风险相关的偏离(AIM 1)。此外,这一努力将仔细
将COVID-19危机的影响作为一个对儿童产生深刻影响的美国范围内的事件
开发(AIM 2)。作为本提案的主要研究成果,所有衍生模型和功能
连通性指标将通过ABCD的中央存储库(AIM 3)共享。这将包括(i)完整的神经系统
(二)10-14岁所有基于任务的数据的“指纹”或功能连接矩阵;
“增长曲线”,以及(iii)供其他实验室重复使用的完整生成概率模型。这些关键数据
捐款将减轻大量研究实验室的后勤负担,并进一步促进广泛使用
ABCD数据,推动可比性和重复性的单一主题的预测研究,以确定
青年开始使用药物的可靠预测因素。这是迈向精确精神病学的关键一步,
阐明在不断变化的经济和社会发展的紧迫背景下造成脆弱性的个人差异因素,
2019冠状病毒病大流行。需要这些预测因子来理解物质的发展轨迹-
使用表型并为早期风险模型和预防性干预工作提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Danilo Bzdok其他文献
Danilo Bzdok的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Danilo Bzdok', 18)}}的其他基金
Application of a Bayesian strategy to ABCD: Identification of substance use risk and COVID-19 effects on neurodevelopment
贝叶斯策略在 ABCD 中的应用:识别物质使用风险和 COVID-19 对神经发育的影响
- 批准号:
10365250 - 财政年份:2022
- 资助金额:
$ 31.8万 - 项目类别:
Investigating the impact of loneliness on brain aging and pre-symptomatic Alzheimer's disease progression
研究孤独对大脑衰老和阿尔茨海默病症状前进展的影响
- 批准号:
10774062 - 财政年份:2020
- 资助金额:
$ 31.8万 - 项目类别:
Investigating the impact of loneliness on brain aging and pre-symptomatic Alzheimer's disease progression
研究孤独对大脑衰老和阿尔茨海默病症状前进展的影响
- 批准号:
10031198 - 财政年份:2020
- 资助金额:
$ 31.8万 - 项目类别:
Investigating the impact of loneliness on brain aging and pre-symptomatic Alzheimer's disease progression
研究孤独对大脑衰老和阿尔茨海默病症状前进展的影响
- 批准号:
10623156 - 财政年份:2020
- 资助金额:
$ 31.8万 - 项目类别:
Investigating the impact of loneliness on brain aging and pre-symptomatic Alzheimer's disease progression
研究孤独对大脑衰老和阿尔茨海默病症状前进展的影响
- 批准号:
10394423 - 财政年份:2020
- 资助金额:
$ 31.8万 - 项目类别:
Investigating the impact of loneliness on brain aging and pre-symptomatic Alzheimer's disease progression
研究孤独对大脑衰老和阿尔茨海默病症状前进展的影响
- 批准号:
10256821 - 财政年份:2020
- 资助金额:
$ 31.8万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.8万 - 项目类别:
Research Grant